Larvol Delta - Calluna-Pharma-AS-Callunaannounced-that-it-has-completed-enrollment-in-its-global-Phase-2-AURORA-study-of-CAL101-for-IPF

CAL101 - Calluna Pharma

https://www.businesswire.com/news/home/20260422512771/en/Calluna-Pharma-Completes-Enrollment-in-Phase-2-AURORA-Study-of-CAL101-for-Idiopathic-Pulmonary-Fibrosis-IPF

Apr 22, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next